| 利培酮对躯体化障碍的增效作用 |
| |
| 引用本文： | 钱建军,董莹盈,沈芳.利培酮对躯体化障碍的增效作用[J].中国药物与临床,2010,10(4):389-390. |
| |
| 作者姓名： | 钱建军 董莹盈 沈芳 |
| |
| 作者单位： | 浙江省绍兴市第七人民医院心理科,312000 |
| |
| 基金项目： | 浙江省绍兴市科技局基金 |
| |
| 摘 要： | 目的观察利培酮治疗躯体化障碍患者的增效作用。方法127例躯体化障碍患者随机分为研究组(利培酮+西酞普兰)64例、对照组(西酞普兰)63例,治疗6个月。于治疗前,治疗后1、2、4、6个月末测评汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)、不良反应量表(TESS)。疗效评价以HAMD减分率为标准,不良反应以TESS评分为标准。结果2组HAMD、HAMA评分组间比较均从治疗1个月末开始差异有统计学意义(P<0.05),2组疗效比较差异有统计学意义(P<0.05);各时期TESS评分比较差异无统计学意义(P>0.05)。结论利培酮合并抗抑郁剂治疗躯体化障碍具有增效作用。
|
| 关 键 词： | 躯体型障碍 生物医学研究 利培酮 |
The additional benefits by risperidone in treatment of somatization disorders |
| |
| QIAN Jian-jun,DONG Ying-ying,SHEN Fang.The additional benefits by risperidone in treatment of somatization disorders[J].Chinese Remedies & Clinics,2010,10(4):389-390. |
| |
| Authors: | QIAN Jian-jun DONG Ying-ying SHEN Fang |
| |
| Affiliation: | QIAN Jian-jun,DONG Ying-ying,SHEN Fang.Department of Psychology,Shaoxing Seventh People\'s Hospital,Zhejiang 312000,China |
| |
| Abstract: | Objective To observe the additional benefits by risperidone in treatment of somatization disorders.Methods One hundred and twenty-seven patients with somatization disorders were randomly divided into study group (risperidone+ citalopram,n=64) and control group (citalopram,n=63) on a 6-month therapy.The patients were assessed with HAMD,HAMA and TESS before treatment and at 1,2,4 and 6 months after treatment.The efficacy was evaluated based on reduction rate of HAMD,and the adverse effects based on TESS.Resul... |
| |
| Keywords: | Somatoform disorders Biomedical research Risperidone |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
